fashion -WSS

fashion

author：entertainment 2025-09-06 04:13:15 - browse：58348

A masked person wears Onward Medical’s non-invasive spinal cord stimulator, solving a Rubik's cube — health tech coverage from STAT — Courtesy Onward Medical

After his spinal cord injury in 2014, Sherown Campbell worked hard to regain as much bodily function as he could. Once a dedicated athlete, Campbell had to learn the new limits of his body. One of them, jarringly, was his body’s inability to sweat.

So when Campbell started sweating on his stationary bike for the first time in seven years, it felt surreal. It was late 2021, and Campbell was nearing the end of a clinical trial testing out a device to help paralyzed patients regain movement.

“I felt really refreshed and excited, because you get to this point where normally I’d have to back off or monitor if I’m overheating,” Campbell, 41, said. “To break through that, it just feels clear.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Novo Nordisk to expand supply of Wegovy for U.S. patients

entertainment

WSS

Apple Vision Pro: A first look at health apps on the new VR headset

Medicare drug price negotiation’s day in court

Some dementia cases could be undiagnosed liver disease

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

Covid misinformation case heads to Supreme Court

What we need to know about Arena Bioworks

leisure time

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

How one medical school became remarkably diverse

Let's speed up science by embracing open access publishing

Medicare details structure of new drug price negotiation program

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

Hollywood unions extend contract negotiations for actors

Time to name cancers by genetics, not organ of origin, expert says

In age of alternative facts, a scholarly course on calling out crap

ASCO: Palliative care found as helpful given virtually as in person

How to save PrEP access — and even expand it

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Wikipedia

A $475,000 price tag for a new cancer drug: crazy or meh?

ASCO: AstraZeneca's hat trick, and palliative care's spotlight

Let's speed up science by embracing open access publishing

Woodcock on FDA’s accelerated approval and her next chapter

Commercial surrogacy can be ethical, despite pope’s claims

Shifting the focus from loneliness to social health

hotspot

entertainment

Wikipedia

entertainment